MARINA BIOTECH
Our mission is to provide effective and patient centric treatment for hypertension- including resistant hypertension. In doing so creating a universal platform for the effective treatment of hypertension as well as for the distribution of fixed dose combination [FDC] hypertensive drugs such as Prestalia® and those in our pipeline. The company commercial product Prestalia® is approved by US FDA for the treatment of hypertension and being commercialized through the DyrctAxess platform. The com... pany is also developing and commercializing late stage, non-addictive pain therapeutics. The company’s ‘next-generation of celecoxib,’ including IT-102 and IT-103, are designed to control the dangerous side-effect of edema that prohibits the drug from being prescribed at higher doses. These have the potential of replacing opioids and combatting the opioid epidemic.
MARINA BIOTECH
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1983-01-01
Address:
City Of Industry, California, United States
Country:
United States
Website Url:
http://www.marinabio.com
Total Employee:
11+
Status:
Closed
Contact:
626-964-5788
Email Addresses:
[email protected]
Total Funding:
19.9 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Advanced Pain Care
Physicians & Surgeon Pain Management
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
GCR
Pattient Intelligence for the new generation
GeneLook
Patient Responsive DNA-sharing Platform
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-07-24 | DyrctAxess | DyrctAxess acquired by Marina Biotech | N/A |
| 2010-07-28 | Novosom | Novosom acquired by Marina Biotech | N/A |
| 2010-04-01 | Cequent Pharmaceuticals | Cequent Pharmaceuticals acquired by Marina Biotech | 46 M USD |
Investors List
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Post-IPO Equity - Marina Biotech
Steven T. Newby
Steven T. Newby investment in Post-IPO Equity - Marina Biotech
Official Site Inspections
http://www.marinabio.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Marina Biotech"
The MarineBio Conservation Society
2 days ago · Since 1998, the MarineBio Conservation Society (MarineBio) has been a nonprofit organization driven by passionate volunteers. Our mission is to inspire and educate people …See details»
marinabiolab - MarinaBioLab
MarinaBioLab can help you set up or upgrade your CLIA laboratory quickly and efficiently. Our expert team provides comprehensive services, including staffing, buildout, machinery, and more to ensure compliance with regulations. We are …See details»
Marina Biotech - Crunchbase Company Profile
View contacts for Marina Biotech to access new leads and connect with decision-makers. Our mission is to provide effective and patient centric treatment for hypertension- including resistant hypertension.See details»
Marine Conservation Organizations
Today over 100 non-government organizations, fishers organizations and law and policy institutes worldwide are working together under the umbrella of the DSCC to protect vulnerable deep-sea ecosystems. We have two main goals: To …See details»
Marina Biotech, Inc. (MRNA) Provides Organizational Update
May 16, 2014 · BOSTON, MA-- (Marketwired - May 14, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development …See details»
Marina Biotech and MiNA Therapeutics Announce License …
Dec 18, 2014 · Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, and MiNA Therapeutics …See details»
Marina Biotech Announces Agreement for Drug …
Jan 16, 2018 · Under the agreement, Autotelic Bio, a Korean based biotechnology company, will obtain a perpetual license to have the right and responsibility to begin clinical development of …See details»
MarinBio: Leading CRO for Drug Development
MarinBio is a Contract Research Organization (CRO) with 30 Years of Preclinical & Clinical Expertise, Delivering Innovation, and Transformative Results with Exceptional CommunicationSee details»
Marina Biotech Announces a License Agreement to …
Marina Biotech, Inc. a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, …See details»
Marina Biotech Appoints Chief Commercial Officer to Lead …
Jun 26, 2017 · Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, …See details»
Marina Biotech, Inc. Announces That Licensee Mirna
Jun 12, 2014 · Marina Biotech is an oligonucleotide therapeutics company with broad drug discovery technologies providing the ability to develop proprietary single and double-stranded …See details»
Marina Biotech Announces That Licensee ProNAi …
Dec 5, 2012 · Marina Biotech, Inc. , a leading nucleic acid-based drug discovery and development company, today announced that the Company's licensee, ProNAi Therapeutics, has reported …See details»
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) …
Marina Biotech's goal is to improve human health through the development of RNAi- and oligonucleotide-based compounds and drug delivery technologies that together provide …See details»
Marina Biotech Acquires RNA Delivery Assets of Novosom …
Aug 4, 2010 · Marina Biotech (formerly known as MDRNA, Inc.) is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA …See details»
Marina Biotech Announces Name Change to Adhera …
Oct 9, 2018 · Adhera Therapeutics, Inc. is a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes. The company is …See details»
Marina Biotech and ProNAi Therapeutics Announce
Mar 14, 2012 · About Marina Biotech, Inc. Marina Biotech is a biotechnology company focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple …See details»
Marina Biotech Acquires Prestalia(R), a U.S. FDA …
Jun 6, 2017 · Marina Biotech's focus is to treat the intersection of arthritis, pain, hypertension, and oncology diseases using combination therapies of already approved drugs. The company is …See details»
Marina Biotech Announces That Licensee ProNAi
Dec 5, 2012 · Marina Biotech is a biotechnology company focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple mechanisms of …See details»
Marina Biotech’s CEQ508 Granted FDA Fast Track …
Marina Biotech, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CEQ508, an investigational RNAi therapeutic for the …See details»
Marina Biotech Completes Share Issuance at a Valuation …
Feb 10, 2017 · Marina Biotech is a biotechnology company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, …See details»